Adam Johnson

Adam Johnson has over a decade of experience in financial analysis and general ledger management. Currently serving as the General Ledger Systems Manager at Mallinckrodt Pharmaceuticals since September 2013, Adam has also held the position of Sr. Financial Analyst. Prior to this role, Adam worked at Covidien (Medtronic Minimally Invasive Therapies Group) from November 2009 to September 2013 as a Sr. Capital Analyst and Capital Analyst. Adam holds a Bachelor of Science in Business Administration with a focus on Accounting and Finance from Rockhurst University, earned between 2004 and 2008.